Daniel J Levitt's Net Worth
$221 Thousand
Who is Daniel J Levitt?
Daniel J Levitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CYTRX CORP, DYNAVAX TECHNOLOGIES CORP, Sorrento Therapeutics, Inc., and AQUINOX PHARMACEUTICALS, INC.
SEC CIK
Daniel J Levitt's CIK is 0001278711
Past Insider Trading and Trends
2014 was Daniel J Levitt's most active year for acquiring shares with 6 total transactions. Daniel J Levitt's most active month to acquire stocks was the month of November. 2018 was Daniel J Levitt's most active year for disposing of shares, totalling 2 transactions. Daniel J Levitt's most active month to dispose stocks was the month of April. 2005 saw Daniel J Levitt paying a total of $374,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2018 Daniel J Levitt cashed out on 7,812 shares for a total of $49,489.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CYTRX CORP (LADX) Snapshot price: $1.5
EVP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4/A
| +163.84% | 100K |
—
|
—
| 161.04K |
Jan 1
| |||
Form 4/A
| +172.46% | 100K |
—
|
—
| 157.98K |
Jan 1
| |||
Form 4/A
| +173.29% | 100K |
—
|
—
| 157.71K |
Jan 1
| |||
Form 4
| +87.50% | 100K |
—
|
—
| 214.29K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4/A
| +699.99% | 100K |
—
|
—
| 114.29K |
Dec 31
| |||
Form 4
| +100.00% | 100K |
—
|
—
| 200K |
Dec 31
| |||
Form 4
|
∞
| 100K |
$0.29 | $28,750.00 | 100K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.945
Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.0375
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AQUINOX PHARMACEUTICALS, INC (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$11.62 | -$8,241.66 |
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |